The impact of insomnia and coexisting conditions on your organization

Over 32% of the US population struggle with sleep difficulty, while 22% have received clinical diagnoses for insomnia disorder. Insomnia alone can substantially impact organizations — employees with insomnia cost, on average, $6,412 more in healthcare spend¹ and $3,098 more in lost productivity costs. Additionally, employees struggling with insomnia have a 7x greater risk of being involved in industrial accidents in the workplace.

And unfortunately, insomnia can increase employees’ likelihood of developing other costly diseases as well — known as comorbid conditions (conditions that occur at the same time).

Here, we’ll discuss some common insomnia-related comorbidities and key takeaways for employers interested in learning how to address employees’ conditions before they progress.

Depression

Depression is one of the most common comorbid conditions associated with insomnia — those with insomnia are 2.83x more likely to develop depression. Depression can lead to a hefty price tag for employers, with treatment costing anywhere from $6,000-$11,000 per year. Likewise, depression can result in psychological changes such as ruminating on problems and negative thoughts, which can lead to more sleep difficulties.

Substance use disorders

Those with insomnia are also 1.35x more likely to develop alcohol use disorders. In addition to concerns of lost productivity, absenteeism, and workplace absences and injuries, alcohol use can cost employers up to $10,000 annually per employee in healthcare costs.

Heart disease

Insomnia can have an impact on physical health as well. Those with insomnia are 6.4x more likely to develop heart disease risk factors. As the leading cause of death in the US, heart disease poses a serious threat to employee health outcomes. In addition, heart disease can drive costs of just under $20,000 per year per employee in health care costs.

Diabetes

Another disease that impacts millions of people in the US is diabetes. And, as you may already know, diabetes isn’t cheap — the condition can cost employers up to $10,000 a year in healthcare costs per employee. And, you guessed it — those with insomnia are 2.95x more likely to have diabetes.

Addressing poor sleep and insomnia early on is necessary

Given the alarming statistics above, it’s clear that insomnia and its many commonly occurring comorbid conditions have a massive impact on your workforce’s health. Unfortunately, these are only a few comorbid conditions associated with poor sleep.

Employers must prioritize addressing insomnia in their workforce before conditions escalate — for the sake of employees’ health, most importantly, and also because of the cost-saving potential.

That’s why Big Health delivers SleepioRx, a clinical-grade digital insomnia treatment designed for remission. SleepioRx teaches cognitive behavioral therapy techniques that allow employees to cope, manage, and overcome their sleep troubles or insomnia before they progress. In a clinical trial, 76% of participants experienced significant improvement in their insomnia using SleepioRx. In another study, SleepioRx improved depressive symptoms across various demographic groups.

By adding effective insomnia treatments to your toolkit, you can improve the physical and mental health of your organization so your workforce can focus on what matters most.

Contact us today if you’d like to speak more about adding SleepioRx to your benefits package.

1. Internal Data. (2023).

SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia/insomnia disorder as an adjunct to usual care in patients aged 18 and older. Sleepio is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider. Patients should read the indications for use.

DOC-2694 Effective 08/2024

‍